OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 02, 2021
The need for real-time monitoring and control has spurred the development of new analytical tools.
December 03, 2020
The collaboration addresses the need for risk mitigation plans in cell therapies.
December 02, 2020
A holistic approach to validation and quality assurance is essential.
November 01, 2020
The shift to single-use technologies is driving the need for innovation in PAT-friendly sensor technologies.
October 16, 2020
AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.
September 01, 2020
As technology matures, inefficiencies and process limitations in downstream process chromatography are improved.
August 02, 2020
Process modeling offers an opportunity to troubleshoot for and anticipate difficult aspects of a bioprocess.
July 01, 2020
Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach.
May 01, 2020
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
Synthetic biology has advanced the scope and scale with which biologically derived therapeutics can be developed.